Right Ventricular Hypertrophy Is Associated With Cardiovascular Events in Hypertrophic Cardiomyopathy: Evidence From Study With Magnetic Resonance Imaging

Canadian Journal of Cardiology

Volumn 31, Issue 6, 2015, Pages 702-708

  Nagata, Yoji ^a   Konno, Tetsuo ^a,b   Fujino, Noboru ^a   Hodatsu, Akihiko ^a   Nomura, Akihiro ^a   Hayashi, Kenshi ^a   Nakamura, Hiroyuki ^a,b   Kawashiri, Masa aki ^a   Yamagishi, Masakazu ^a,b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GADOLINIUM PENTETATE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PREVALENCE; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HYPERTROPHY, RIGHT VENTRICULAR; JAPAN; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; SURVIVAL;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; INCIDENCE; JAPAN; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 84929834064     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.12.036     Document Type: Article

References (31)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996, 93:841-842.
2. Kawashiri M.A., Hayashi K., Konno T., et al. Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessels 2014, 29:129-141.
3. Konno T., Chang S., Seidman J.G., et al. Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 2010, 25:205-209.
4. Konno T., Chen D., Wang L., et al. Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 2010, 107:18097-18102.
5. Fujino N., Konno T., Hayashi K., et al. Impact of systolic dysfunction in genotyped hypertrophic cardiomyopathy. Clin Cardiol 2013, 36:160-165.
6. Teekakirikul P., Eminaga S., Toka O., et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. JClin Invest 2010, 120:3520-3529.
7. Lai W.W., Gauvreau K., Rivera E.S., et al. Accuracy of guideline recommendations for two dimensional quantification of the right ventricle by echocardiography. Int J Cardiovasc Imaging 2008, 24:691-698.
8. Mertens L.L., Friedberg M.K. Imaging the right ventricle-current state of the art. Nat Rev Cardiol 2010, 7:551-563.
9. Valsangiacomo B.E., Mertens L.L. Imaging the right heart: the use of integrated multimodality imaging. Eur Heart J 2012, 33:949-960.
10. Rudski L.G., Lai W.W., Afilalo J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. JAm Soc Echocardiogr 2010, 23:685-713.
11. Maron M.S. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. JCardiovasc Magn Reson 2012, 14:13.
12. Keeling A.N., Carr J.C., Choudhury L. Right ventricular hypertrophy and scarring in mutation positive hypertrophic cardiomyopathy. Eur Heart J 2010, 31:381.
13. Maron M.S., Hauser T.H., Dubrow E., et al. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 2007, 100:1293-1298.
14. Fluechter S., Kuschyk J., Wolpert C., et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. JCardiovasc Magn Reson 2010, 12:30.
15. Elliott P.M., Anastasakis A., Borger M.A., et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014, 35:2733-2779.
16. Kawut S.M., Barr R.G., Lima J.A., et al. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)-right ventricle study. Circulation 2012, 126:1681-1688.
17. Fischer Y., Filzmaier K., Stiegler H., et al. Evaluation of new, rapid, bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001, 47:591-594.
18. Oh J.K., Sewar B., Tajik A.J. Doppler Echocardiography and Color Flow Imaging: Comprehensive Noninvasive Hemodynamic Assessment. The Echo Manual 2006, 59-98. Lippincott, Williams & Wilkins, Philadelphia, PA. 3rd Ed.
19. Woodard P.K., Bluemke D.A., Cascade P.N., et al. ACR practice guideline for the performance and interpretation of cardiac magnetic resonance imaging (MRI). JAm Coll Radiol 2006, 3:665-676.
20. Walker L.A., Buttrick P.M. The right ventricle: biologic insights and response to disease: updated. Curr Cardiol Rev 2013, 9:73-81.
21. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
22. Haddad F., Doyle R., Murphy D.J., et al. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008, 117:1717-1731.
23. Meyer P., Filippatos G.S., Ahmed M.I., et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010, 121:252-258.
24. de Groote P., Millaire A., Foucher-Hossein C., et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. JAm Coll Cardiol 1998, 32:948-954.
25. Stierle U., Sheikhzadeh A., Shakibi J.G., et al. Right ventricular obstruction in various types of hypertrophic cardiomyopathy. Jpn Heart J 1987, 28:115-125.
26. Mozaffarian D., Caldwell J.H. Right ventricular involvement in hypertrophic cardiomyopathy: a case report and literature review. Clin Cardiol 2001, 24:2-8.
27. Maeda M., Yamakado J., Nakano T. Right ventricular diastolic function in patients with hypertrophic cardiomyopathy-an invasive study. Jpn Circ J 1999, 63:681-687.
28. D'Andrea A., Caso P., Bossone E., et al. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis. Eur J Echocardiogr 2010, 11:492-500.
29. Larrazet F., Pellerin D., Fournier C., et al. Right and left isovolumic ventricular relaxation time intervals compared in patients by means of a single-pulse Doppler method. JAm Soc Echocardiogr 1997, 10:699-706.
30. Ellims A.H., Iles L.M., Ling L.H., et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. JCardiovasc Magn Reson 2012, 14:76.
31. Fujita T., Fujino N., Anan R., et al. Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy. JACC Heart Fail 2013, 1:459-466.